© 1988 British Society for Rheumatology
brief-report |
CAMPYLOBACTER PYLORI ASSOCIATED GASTRITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS TAKING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
1Gastroenterology Unit Royal Infirmary, Glasgow G31 2ER, UK
2Department of Pathology Royal Infirmary, Glasgow G31 2ER, UK
3Centre for Rheumatic Diseases Royal Infirmary, Glasgow G31 2ER, UK
Correspondence to:
4Address correspondence to Dr. R. Upadhyay
Fifty-two patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs were studied in order to assess the carriage rate of Campylobacterpylori (C. pylori) with reference to dyspeptic symptoms, endoscopic appearance and antral histology. All patients were interviewed using a standard gastrointestinal symptom scoring questionnaire and underwent endoscopy at which two antral biopsies were obtained. Sections were examined for the presence and severity of gastritis and of C. pylori.
Forty-four of 52 patients (85%) had histological evidence of gastritis. Twenty-six of 44 (59%) patients with gastritis were positive for C. pylori. Twenty-six of 28 patients with 'active' (polymorph infiltration) chronic gastritis were positive for C. pylori (p <0.002). Sixteen of 26 bacteria-positive patients had gastrointestinal symptoms compared with eight of 26 bacteria-negative patients (p < 0.05) and this may have therapeutic implications. There was no correlation between the presence of organisms and the appearances at endoscopy.
KEY WORDS: 'Active' chronic gastritis, Prevalence, Dyspepsia, Endoscopy.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X Calvet, J Gratacos, J Font, M Larrosa, I Sanfeliu, and M Roque Helicobacter pylori does not play a part in the dyspeptic complaints of rheumatology patients receiving long term treatment with non-steroidal anti-inflammatory drugs Ann Rheum Dis, July 1, 2002; 61(7): 641 - 643. [Abstract] [Full Text] [PDF] |
||||
